These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 18765163)
1. Drug-eluting stents: is new necessarily better? Waksman R Lancet; 2008 Sep; 372(9644):1126-8. PubMed ID: 18765163 [No Abstract] [Full Text] [Related]
2. Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial. Windecker S; Serruys PW; Wandel S; Buszman P; Trznadel S; Linke A; Lenk K; Ischinger T; Klauss V; Eberli F; Corti R; Wijns W; Morice MC; di Mario C; Davies S; van Geuns RJ; Eerdmans P; van Es GA; Meier B; Jüni P Lancet; 2008 Sep; 372(9644):1163-73. PubMed ID: 18765162 [TBL] [Abstract][Full Text] [Related]
3. Biodegradable drug-eluting stents: promises and pitfalls. Di Mario C; Ferrante G Lancet; 2008 Mar; 371(9616):873-4. PubMed ID: 18342665 [No Abstract] [Full Text] [Related]
4. The bioabsorption process: tissue and cellular mechanisms and outcomes. Vorpahl M; Finn AV; Nakano M; Virmani R EuroIntervention; 2009 Dec; 5 Suppl F():F28-35. PubMed ID: 22100673 [No Abstract] [Full Text] [Related]
6. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries). Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443 [TBL] [Abstract][Full Text] [Related]
7. Very late stent thrombosis with newer drug-eluting stents: no longer an issue? de la Torre Hernández JM; Windecker S Rev Esp Cardiol (Engl Ed); 2012 Jul; 65(7):595-8. PubMed ID: 22627073 [No Abstract] [Full Text] [Related]
8. Long-term follow-up of the First In Man experience with everolimus-eluting stents. Kimmelstiel C Catheter Cardiovasc Interv; 2010 Jun; 75(7):1004-5. PubMed ID: 20517960 [No Abstract] [Full Text] [Related]
9. Drug-eluting stents - what should be improved? Steffel J; Eberli FR; Lüscher TF; Tanner FC Ann Med; 2008; 40(4):242-52. PubMed ID: 18428018 [TBL] [Abstract][Full Text] [Related]
10. [Very late stent thrombosis after implantation of sirolimus eluting coronary stents]. Xu L; Wang LF; Yang XC; Ge YG; Wang HS; Li WM; Ni ZH; Liu Y; Xia K; Cui L Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Apr; 35(4):312-5. PubMed ID: 17711654 [TBL] [Abstract][Full Text] [Related]
11. Real polymer-free sirolimus- and probucol-eluting versus biodegradable polymer sirolimus-eluting stents for obstructive coronary artery disease: DKPLUS-Wave 1, a multicenter, randomized, prospective trial. Chen SL; Ye F; Zhang JJ; Zou JJ; Qian XS; Li F; Yang S; Ge Z; Shan SJ; Li XB; Xu T; Kan J; Lin L; Han YL Cardiovasc Ther; 2013 Aug; 31(4):193-200. PubMed ID: 22954234 [TBL] [Abstract][Full Text] [Related]